CLINICAL TRIALS

You have access
Toward a Generalized Framework of Core Measurement Areas in Clinical Trials: A Position Paper for OMERACT 11
Maarten Boers, Leanne Idzerda, John R. Kirwan, Dorcas Beaton, Reuben Escorpizo, Annelies Boonen, Susan Magasi, Ian Sinha, Gerold Stucki and Peter Tugwell

The Journal of Rheumatology May 1 2014, 41 (5) 978-985; DOI: https://doi.org/10.3899/jrheum.131307
You have access
Can We Decide Which Outcomes Should Be Measured in Every Clinical Trial? A Scoping Review of the Existing Conceptual Frameworks and Processes to Develop Core Outcome Sets
Leanne Idzerda, Tamara Rader, Peter Tugwell and Maarten Boers

The Journal of Rheumatology May 1 2014, 41 (5) 986-993; DOI: https://doi.org/10.3899/jrheum.131308
You have access
Updating the OMERACT Filter: Core Areas as a Basis for Defining Core Outcome Sets
John R. Kirwan, Maarten Boers, Sarah Hewlett, Dorcas Beaton, Clifton O. Bingham III, Ernest Choy, Philip G. Conaghan, Maria-Antonietta D’Agostino, Maxime Dougados, Daniel E. Furst, Francis Guillemin, Laure Gossec, Désirée M. van der Heijde, Margreet Kloppenburg, Tore K. Kvien, Robert B.M. Landewé, Sarah L. Mackie, Eric L. Matteson, Philip J. Mease, Peter A. Merkel, Mikkel Ostergaard, Lesley Ann Saketkoo, Lee Simon, Jasvinder A. Singh, Vibeke Strand and Peter Tugwell

The Journal of Rheumatology May 1 2014, 41 (5) 994-999; DOI: https://doi.org/10.3899/jrheum.131309
You have access
Adalimumab, Etanercept, Infliximab, and the Risk of Tuberculosis: Data from Clinical Trials, National Registries, and Postmarketing Surveillance
Fabrizio Cantini, Laura Niccoli and Delia Goletti

The Journal of Rheumatology Supplement May 1 2014, 91 47-55; DOI: https://doi.org/10.3899/jrheum.140102
You have access
Establishing a Core Domain Set to Measure Rheumatoid Arthritis Flares: Report of the OMERACT 11 RA Flare Workshop
Vivian P. Bykerk, Elisabeth Lie, Susan J. Bartlett, Rieke Alten, Annelies Boonen, Robin Christensen, Daniel E. Furst, Sarah Hewlett, Amye L. Leong, Anne Lyddiatt, Lyn March, James E. May, Pam Montie, Ana-Maria Orbai, Christoph Pohl, Marieke Scholte Voshaar, Thasia Woodworth, Clifton O. Bingham III and Ernest H. Choy

The Journal of Rheumatology April 1 2014, 41 (4) 799-809; DOI: https://doi.org/10.3899/jrheum.131252
Open Access
A Randomized Controlled Trial of an Internal Family Systems-based Psychotherapeutic Intervention on Outcomes in Rheumatoid Arthritis: A Proof-of-Concept Study
Nancy A. Shadick, Nancy F. Sowell, Michelle L. Frits, Suzanne M. Hoffman, Shelley A. Hartz, Fran D. Booth, Martha Sweezy, Patricia R. Rogers, Rina L. Dubin, Joan C. Atkinson, Amy L. Friedman, Fernando Augusto, Christine K. Iannaccone, Anne H. Fossel, Gillian Quinn, Jing Cui, Elena Losina and Richard C. Schwartz

The Journal of Rheumatology November 1 2013, 40 (11) 1831-1841; DOI: https://doi.org/10.3899/jrheum.121465
You have access
Patient-reported Health-related Quality of Life with Apremilast for Psoriatic Arthritis: A Phase II, Randomized, Controlled Study
Vibeke Strand, Georg Schett, ChiaChi Hu and Randall M. Stevens

The Journal of Rheumatology July 1 2013, 40 (7) 1158-1165; DOI: https://doi.org/10.3899/jrheum.121200
Open Access
Subcutaneously Administered Ofatumumab in Rheumatoid Arthritis: A Phase I/II Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics
Regina Kurrasch, Judith C. Brown, Myron Chu, Jenny Craigen, Philip Overend, Bela Patel, Steven Wolfe and David J. Chang

The Journal of Rheumatology July 1 2013, 40 (7) 1089-1096; DOI: https://doi.org/10.3899/jrheum.121118

Main menu

User menu

Search

CLINICAL TRIALS

Pages

Content

Resources

Subscribers

More